Clinical trial
Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia
NCT00760318 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia
- Lead sponsor
- University of South Florida
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- October 31, 2007
- Enrollment
- 17 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical dystonia